Robert Bulten, MD | |
4340 Burlingame Ave Sw, Wyoming, MI 49509-3770 | |
(616) 475-7922 | |
(616) 475-7926 |
Full Name | Robert Bulten |
---|---|
Gender | Male |
Speciality | Pediatrics - Developmental - Behavioral Pediatrics |
Location | 4340 Burlingame Ave Sw, Wyoming, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023177268 | NPI | - | NPPES |
3305965 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0006X | Pediatrics - Developmental - Behavioral Pediatrics | 4301028703 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robert Bulten, MD 4340 Burlingame Ave Sw, Wyoming, MI 49509-3770 Ph: (616) 475-7922 | Robert Bulten, MD 4340 Burlingame Ave Sw, Wyoming, MI 49509-3770 Ph: (616) 475-7922 |
News Archive
Primary immunodeficiency disorders are a group of more than 300 single gene defects that affect the role of the immune system and prevent it from functioning properly. When Roswell Park Cancer Institute researchers evaluated the overall and site-specific incidence of cancer among patients registered in the United States Immune Deficiency Network, they found increased cancer incidence rates among patients with primary immunodeficiency diseases — and, in particular, a significant increase in lymphoma cases.
Stateline examines the factors that affect pricing on the online marketplaces. News outlets also report on recent developments in California and Washington, D.C.
RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.
During the past 15 years, the number of critical access hospitals – those with fewer than 25 acute care beds that receive higher reimbursements and other considerations from Medicare to help sustain them – has increased substantially, representing a quarter of all U.S. acute care hospitals in 2011.
The average academic grades of children and teens with moderate to severe obstructive sleep apnea are worse than the grades of students who have no sleep-disordered breathing, according to a research abstract that will be presented Tuesday, June 8, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.
› Verified 8 days ago
Dr. Janet F Johns, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 56th St Sw, Wyoming, MI 49509 Phone: 616-514-3803 Fax: 616-243-1170 | |
Dr. Charles G. Lawrence, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 56th St Sw, Wyoming, MI 49509 Phone: 616-243-5707 Fax: 616-243-1170 | |
Tiffany Allyn Letts, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2215 44th St Sw, Wyoming, MI 49519 Phone: 616-252-8300 Fax: 616-252-8461 | |
Dr. Rebecca L. Maki, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 56th St Sw, Wyoming, MI 49509 Phone: 616-243-5707 Fax: 616-243-1170 | |
Dr. Jamie D. Bosch, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 56th St Sw, Wyoming, MI 49509 Phone: 616-243-5707 Fax: 616-243-1170 | |
Dr. Andrew Dillon Smith, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2215 44th St Sw, Wyoming, MI 49519 Phone: 616-252-8300 |